Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
- Journal
- ACS Nano
In The Last Decade
doi.org/10.1021/acsnano.7b07643 →Countries where authors are citing Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
This map shows the geographic impact of Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction more than expected).
Fields of papers citing Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
This network shows the impact of Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction.
About Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
This paper, published in 2018, received 354 indexed citations . Written by Yaoxiang Sun, Hui Shi, Siqi Yin, Cheng Ji, Xu Zhang, Bin Zhang, Peipei Wu, Ying‐Hong Shi, Fei Mao and Yongmin Yan covering the research area of Molecular Biology, Genetics and Surgery. It is primarily cited by scholars working on Molecular Biology (266 citations), Cancer Research (141 citations) and Genetics (87 citations). Published in ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/acsnano.7b07643.